The (TTTA) n polymorphism in intron 4 of CYP19 and the polycystic ovary syndrome risk in a Chinese population
Authors:
- 10 May 2013
- journal article
- research article
- Published by Springer Nature in Molecular Biology Reports
- Vol. 40 (8) , 5041-5047
Abstract
No abstract availableKeywords
This publication has 26 references indexed in Scilit:
- CYP19 gene: a genetic modifier of polycystic ovary syndrome phenotypeFertility and Sterility, 2010
- Association between CYP19 gene SNP rs2414096 Polymorphism and polycystic ovary syndrome in Chinese womenBMC Medical Genetics, 2009
- Association of Androgen Receptor CAG Repeat Polymorphism and Polycystic Ovary SyndromeThe Journal of Clinical Endocrinology & Metabolism, 2008
- Association between gynecomastia and aromatase (CYP19) polymorphismsEuropean Journal of Endocrinology, 2008
- CYP1B1 and CYP19 gene polymorphisms and breast cancer incidence: no association in the ARIC studyCancer Letters, 2004
- A tetranucleotide repeat polymorphism inCYP19 and breast cancer riskInternational Journal of Cancer, 2000
- Genetic variants of CYP19 (aromatase) and breast cancer riskOncogene, 2000
- Polymorphisms in the human aromatase cytochrome P450 gene (CYP19) and breast cancer riskCarcinogenesis, 2000
- A rare CYP19 (aromatase) variant may increase the risk of breast cancerPharmacogenetics, 1998
- Use of Molecular Probes to Study Regulation of Aromatase Cytochrome P-4501Biology of Reproduction, 1990